Search

Search Constraints

You searched for: Author/Creator Domingo, Pere

Search Results

1. 96-Week Results of Abacavir/Lamivudine versus Tenofovir/Emtricitabine, plus Efavirenz, in Antiretroviral-Naive, HIV-1-Infected Adults: Assert Study. Issue 7 (October 2013)

2. A baseline metabolomic signature is associated with immunological CD4+ T-cell recovery after 36 months of antiretroviral therapy in HIV-infected patients. (13th March 2018)

3. Adipose tissue aging partially accounts for fat alterations in HIV lipodystrophy. (31st December 2022)

4. Aging is associated with increased FGF21 levels but unaltered FGF21 responsiveness in adipose tissue. Issue 5 (24th July 2018)

7. Associations of modern initial antiretroviral drug regimens with all-cause mortality in adults with HIV in Europe and North America: a cohort study. Issue 6 (June 2022)

9. Atherogenic properties of LDL particles after switching from Truvada or Kivexa plus lopinavir/r to lamivudine plus lopinavir/r: OLE-MET substudy. Issue 2 (4th March 2017)

10. Atherogenic properties of lipoproteins in HIV patients starting atazanavir/ritonavir or darunavir/ritonavir: a substudy of the ATADAR randomized study. (23rd December 2014)